Purple Biotech Ltd (PPBT:NASDAQ) closed at $1.34 on November 9, 2026, up 4.69% on the day. The stock trades 84.9% below its 52-week high of $8.90 and 47.3% above its 52-week low of $0.910. Over the past year, it lost 84.2%. Purple Biotech Ltd is part of the Health Care sector.
In 252 trading sessions since November 7, 2025, PPBT closed higher on 110 days (44%). Its best day was April 17, 2026 (+19.66%) and its worst was June 11, 2026 (-47.97%). The stock moved 10% or more in a single session 12 times. It opened at least 5% above the previous day's high 4 times.
Purple Biotech Ltd is a clinical-stage company focused on advancing first-in-class therapies to overcome tumor immune evasion and drug resistance, to create treatments for people with cancer. Its oncology pipeline includes NT219 and CM24.
Find more stocks like PPBT with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.